| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CRL - Creightons Plc | SELL | -28 @ USD 105.92 | USD -2,966 | The ETF sold 28 shares of CRL on 2025-04-15. The shares were previously bought for an average price of USD 171.274. The Creightons Plc shares were sold for -38.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,830 The average price that the ETF previously sold CRL share for is USD 191.607 which is higher than the selling price of USD 105.92 on 2025-04-15. |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 146.28 | USD -3,657 | The ETF sold 25 shares of DVA on 2025-04-15. The shares were previously bought for an average price of USD 155.622. The DaVita HealthCare Partners Inc shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 234 The average price that the ETF previously sold DVA share for is USD 154.001 which is higher than the selling price of USD 146.28 on 2025-04-15. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 64.28 | USD -4,435 | The ETF sold 69 shares of HSIC on 2025-04-15. The shares were previously bought for an average price of USD 73.4276. The Henry Schein Inc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 631 The average price that the ETF previously sold HSIC share for is USD 71.1895 which is higher than the selling price of USD 64.28 on 2025-04-15. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 51.07 | USD -4,443 | The ETF sold 87 shares of TECH on 2025-04-15. The shares were previously bought for an average price of USD 66.454. The Bio-Techne Corp shares were sold for -23.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,338 The average price that the ETF previously sold TECH share for is USD 71.6256 which is higher than the selling price of USD 51.07 on 2025-04-15. |
| MRNA - Moderna Inc | SELL | -184 @ USD 26.24 | USD -4,828 | The ETF sold 184 shares of MRNA on 2025-04-15. The shares were previously bought for an average price of USD 36.3054. The Moderna Inc shares were sold for -27.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,852 The average price that the ETF previously sold MRNA share for is USD 42.4046 which is higher than the selling price of USD 26.24 on 2025-04-15. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 65.93 | USD -4,879 | The ETF sold 74 shares of SOLV on 2025-04-15. The shares were previously bought for an average price of USD 74.8416. The Solventum Corp. shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 659 The average price that the ETF previously sold SOLV share for is USD 70.2311 which is higher than the selling price of USD 65.93 on 2025-04-15. |
| VTRS - Viatris Inc | SELL | -669 @ USD 7.48 | USD -5,004 | The ETF sold 669 shares of VTRS on 2025-04-15. The shares were previously bought for an average price of USD 10.5477. The Viatris Inc shares were sold for -29.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,052 The average price that the ETF previously sold VTRS share for is USD 12.3323 which is higher than the selling price of USD 7.48 on 2025-04-15. |
| INCY - Incyte Corporation | SELL | -89 @ USD 58.46 | USD -5,203 | The ETF sold 89 shares of INCY on 2025-04-15. The shares were previously bought for an average price of USD 69.6912. The Incyte Corporation shares were sold for -16.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,000 The average price that the ETF previously sold INCY share for is USD 73.0989 which is higher than the selling price of USD 58.46 on 2025-04-15. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 175.5 | USD -5,441 | The ETF sold 31 shares of UHS on 2025-04-15. The shares were previously bought for an average price of USD 190.316. The Universal Health Services Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 459 The average price that the ETF previously sold UHS share for is USD 192.975 which is higher than the selling price of USD 175.5 on 2025-04-15. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 164.15 | USD -6,402 | The ETF sold 39 shares of ALGN on 2025-04-15. The shares were previously bought for an average price of USD 188.921. The Align Technology Inc shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 966 The average price that the ETF previously sold ALGN share for is USD 216.825 which is higher than the selling price of USD 164.15 on 2025-04-15. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 95.54 | USD -6,497 | The ETF sold 68 shares of RVTY on 2025-04-15. The shares were previously bought for an average price of USD 113.419. The Revvity Inc. shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,216 The average price that the ETF previously sold RVTY share for is USD 114.721 which is higher than the selling price of USD 95.54 on 2025-04-15. |
| HOLX - Hologic Inc | SELL | -124 @ USD 57.86 | USD -7,175 | The ETF sold 124 shares of HOLX on 2025-04-15. The shares were previously bought for an average price of USD 67.6959. The Hologic Inc shares were sold for -14.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,220 The average price that the ETF previously sold HOLX share for is USD 72.8132 which is higher than the selling price of USD 57.86 on 2025-04-15. |
| BAX - Baxter International Inc | SELL | -280 @ USD 27.8 | USD -7,784 | The ETF sold 280 shares of BAX on 2025-04-15. The shares were previously bought for an average price of USD 33.5986. The Baxter International Inc shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,624 The average price that the ETF previously sold BAX share for is USD 32.5255 which is higher than the selling price of USD 27.8 on 2025-04-15. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 212.5 | USD -8,288 | The ETF sold 39 shares of WST on 2025-04-15. The shares were previously bought for an average price of USD 260.276. The West Pharmaceutical Services Inc shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,863 The average price that the ETF previously sold WST share for is USD 308.56 which is higher than the selling price of USD 212.5 on 2025-04-15. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 77.8 | USD -8,714 | The ETF sold 112 shares of COO on 2025-04-15. The shares were previously bought for an average price of USD 89.6769. The The Cooper Companies, Inc. Common Stock shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,330 The average price that the ETF previously sold COO share for is USD 96.7568 which is higher than the selling price of USD 77.8 on 2025-04-15. |
| BIIB - Biogen Inc | SELL | -80 @ USD 116.98 | USD -9,358 | The ETF sold 80 shares of BIIB on 2025-04-15. The shares were previously bought for an average price of USD 148.189. The Biogen Inc shares were sold for -21.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,497 The average price that the ETF previously sold BIIB share for is USD 159.391 which is higher than the selling price of USD 116.98 on 2025-04-15. |
| PODD - Insulet Corporation | SELL | -38 @ USD 256.425 | USD -9,744 | The ETF sold 38 shares of PODD on 2025-04-15. The shares were previously bought for an average price of USD 269.112. The Insulet Corporation shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of USD 482 The average price that the ETF previously sold PODD share for is USD 260.852 which is higher than the selling price of USD 256.425 on 2025-04-15. |
| MOH - MOH | SELL | -30 @ USD 335.5 | USD -10,065 | The ETF sold 30 shares of MOH on 2025-04-15. The shares were previously bought for an average price of USD 308.09. The MOH shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 822 The average price that the ETF previously sold MOH share for is USD 306.124 so the ETF has sold 30 shares on 2025-04-15 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 335.5 | USD -10,065 | The ETF sold 30 shares of MOH on 2025-04-15. The shares were previously bought for an average price of USD 308.09. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 822 The average price that the ETF previously sold MOH share for is USD 306.124 so the ETF has sold 30 shares on 2025-04-15 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 226.02 | USD -10,171 | The ETF sold 45 shares of LH on 2025-04-15. The shares were previously bought for an average price of USD 241.619. The Laboratory Corporation of America Holdings shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 702 The average price that the ETF previously sold LH share for is USD 235.835 which is higher than the selling price of USD 226.02 on 2025-04-15. |
| WAT - Waters Corporation | SELL | -32 @ USD 323.44 | USD -10,350 | The ETF sold 32 shares of WAT on 2025-04-15. The shares were previously bought for an average price of USD 371.732. The Waters Corporation shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,545 The average price that the ETF previously sold WAT share for is USD 373.626 which is higher than the selling price of USD 323.44 on 2025-04-15. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 323.44 | USD -10,350 | The ETF sold 32 shares of WAT on 2025-04-15. The shares were previously bought for an average price of USD 371.732. The MULETFWATIMETFP shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,545 The average price that the ETF previously sold WAT share for is USD 373.626 which is higher than the selling price of USD 323.44 on 2025-04-15. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 167.23 | USD -10,368 | The ETF sold 62 shares of DGX on 2025-04-15. The shares were previously bought for an average price of USD 166.319. The Quest Diagnostics Incorporated shares were sold for 0.5% higher than average price of previous purchases. This sale made a profit of USD 56 The average price that the ETF previously sold DGX share for is USD 158.823 so the ETF has sold 62 shares on 2025-04-15 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 97.27 | USD -10,602 | The ETF sold 109 shares of ZBH on 2025-04-15. The shares were previously bought for an average price of USD 107.914. The Zimmer Biomet Holdings Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,160 The average price that the ETF previously sold ZBH share for is USD 107.746 which is higher than the selling price of USD 97.27 on 2025-04-15. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1046.58 | USD -11,512 | The ETF sold 11 shares of MTD on 2025-04-15. The shares were previously bought for an average price of USD 1254.84. The Mettler-Toledo International Inc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,291 The average price that the ETF previously sold MTD share for is USD 1244.82 which is higher than the selling price of USD 1046.58 on 2025-04-15. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1046.58 | USD -11,512 | The ETF sold 11 shares of MTD on 2025-04-15. The shares were previously bought for an average price of USD 1254.84. The AMUNDI EUR GOV 710 shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,291 The average price that the ETF previously sold MTD share for is USD 1244.82 which is higher than the selling price of USD 1046.58 on 2025-04-15. |
| STE - STERIS plc | SELL | -54 @ USD 221.04 | USD -11,936 | The ETF sold 54 shares of STE on 2025-04-15. The shares were previously bought for an average price of USD 221.85. The STERIS plc shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 44 The average price that the ETF previously sold STE share for is USD 214.566 so the ETF has sold 54 shares on 2025-04-15 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 149.15 | USD -13,722 | The ETF sold 92 shares of IQV on 2025-04-15. The shares were previously bought for an average price of USD 195.932. The IQVIA Holdings Inc shares were sold for -23.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,304 The average price that the ETF previously sold IQV share for is USD 199.436 which is higher than the selling price of USD 149.15 on 2025-04-15. |
| DXCM - DexCom Inc | SELL | -216 @ USD 69.23 | USD -14,954 | The ETF sold 216 shares of DXCM on 2025-04-15. The shares were previously bought for an average price of USD 78.1718. The DexCom Inc shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,931 The average price that the ETF previously sold DXCM share for is USD 75.3461 which is higher than the selling price of USD 69.23 on 2025-04-15. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -250 @ USD 63.1 | USD -15,775 | The ETF sold 250 shares of GEHC on 2025-04-15. The shares were previously bought for an average price of USD 86.402. The GE HealthCare Technologies Inc. shares were sold for -27.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,826 The average price that the ETF previously sold GEHC share for is USD 81.7278 which is higher than the selling price of USD 63.1 on 2025-04-15. |
| A - Agilent Technologies Inc | SELL | -156 @ USD 103.12 | USD -16,087 | The ETF sold 156 shares of A on 2025-04-15. The shares were previously bought for an average price of USD 130.969. The Agilent Technologies Inc shares were sold for -21.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,344 The average price that the ETF previously sold A share for is USD 133.495 which is higher than the selling price of USD 103.12 on 2025-04-15. |
| RMD - ResMed Inc | SELL | -80 @ USD 213.97 | USD -17,118 | The ETF sold 80 shares of RMD on 2025-04-15. The shares were previously bought for an average price of USD 234.489. The ResMed Inc shares were sold for -8.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,642 The average price that the ETF previously sold RMD share for is USD 239.942 which is higher than the selling price of USD 213.97 on 2025-04-15. |
| CNC - Concurrent Technologies Plc | SELL | -275 @ USD 62.28 | USD -17,127 | The ETF sold 275 shares of CNC on 2025-04-15. The shares were previously bought for an average price of USD 60.022. The Concurrent Technologies Plc shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 621 The average price that the ETF previously sold CNC share for is USD 60.041 so the ETF has sold 275 shares on 2025-04-15 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 404.02 | USD -17,777 | The ETF sold 44 shares of IDXX on 2025-04-15. The shares were previously bought for an average price of USD 438.569. The IDEXX Laboratories Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,520 The average price that the ETF previously sold IDXX share for is USD 424.88 which is higher than the selling price of USD 404.02 on 2025-04-15. |
| CAH - Cardinal Health Inc | SELL | -133 @ USD 134.25 | USD -17,855 | The ETF sold 133 shares of CAH on 2025-04-15. The shares were previously bought for an average price of USD 127.147. The Cardinal Health Inc shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 945 The average price that the ETF previously sold CAH share for is USD 121.356 so the ETF has sold 133 shares on 2025-04-15 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 286.78 | USD -18,641 | The ETF sold 65 shares of HUM on 2025-04-15. The shares were previously bought for an average price of USD 271.518. The Hummingbird Resources PLC shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 992 The average price that the ETF previously sold HUM share for is USD 278.622 so the ETF has sold 65 shares on 2025-04-15 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -65 @ USD 286.78 | USD -18,641 | The ETF sold 65 shares of HUM on 2025-04-15. The shares were previously bought for an average price of USD 271.518. The Humana Inc shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 992 The average price that the ETF previously sold HUM share for is USD 278.622 so the ETF has sold 65 shares on 2025-04-15 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -323 @ USD 70.76 | USD -22,855 | The ETF sold 323 shares of EW on 2025-04-15. The shares were previously bought for an average price of USD 71.1015. The Edwards Lifesciences Corp shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 110 The average price that the ETF previously sold EW share for is USD 70.1362 so the ETF has sold 323 shares on 2025-04-15 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -94 @ USD 284.54 | USD -26,747 | The ETF sold 94 shares of COR on 2025-04-15. The shares were previously bought for an average price of USD 251.456. The Cencora Inc. shares were sold for 13.2% higher than average price of previous purchases. This sale made a profit of USD 3,110 The average price that the ETF previously sold COR share for is USD 244.412 so the ETF has sold 94 shares on 2025-04-15 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -157 @ USD 202.04 | USD -31,720 | The ETF sold 157 shares of BDX on 2025-04-15. The shares were previously bought for an average price of USD 230.837. The Becton Dickinson and Company shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,521 The average price that the ETF previously sold BDX share for is USD 225.794 which is higher than the selling price of USD 202.04 on 2025-04-15. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 557.91 | USD -31,801 | The ETF sold 57 shares of REGN on 2025-04-15. The shares were previously bought for an average price of USD 716.103. The Regeneron Pharmaceuticals Inc shares were sold for -22.1% lower than average price of previous purchases. This resulted in an overall loss of USD 9,017 The average price that the ETF previously sold REGN share for is USD 757.051 which is higher than the selling price of USD 557.91 on 2025-04-15. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 335.55 | USD -32,548 | The ETF sold 97 shares of HCA on 2025-04-15. The shares were previously bought for an average price of USD 337.144. The HCA Holdings Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 155 The average price that the ETF previously sold HCA share for is USD 325.655 so the ETF has sold 97 shares on 2025-04-15 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -244 @ USD 149.22 | USD -36,410 | The ETF sold 244 shares of ZTS on 2025-04-15. The shares were previously bought for an average price of USD 168.375. The Zoetis Inc shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,674 The average price that the ETF previously sold ZTS share for is USD 172.329 which is higher than the selling price of USD 149.22 on 2025-04-15. |
| MCK - McKesson Corporation | SELL | -68 @ USD 692.86 | USD -47,114 | The ETF sold 68 shares of MCK on 2025-04-15. The shares were previously bought for an average price of USD 613.909. The McKesson Corporation shares were sold for 12.9% higher than average price of previous purchases. This sale made a profit of USD 5,369 The average price that the ETF previously sold MCK share for is USD 598.399 so the ETF has sold 68 shares on 2025-04-15 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -687 @ USD 68.92 | USD -47,348 | The ETF sold 687 shares of CVS on 2025-04-15. The shares were previously bought for an average price of USD 62.6022. The CVS Health Corp shares were sold for 10.1% higher than average price of previous purchases. This sale made a profit of USD 4,340 The average price that the ETF previously sold CVS share for is USD 54.9918 so the ETF has sold 687 shares on 2025-04-15 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 328.63 | USD -48,966 | The ETF sold 149 shares of CI on 2025-04-15. The shares were previously bought for an average price of USD 315.276. The Cigna Corp shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 1,990 The average price that the ETF previously sold CI share for is USD 312.617 so the ETF has sold 149 shares on 2025-04-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 437.77 | USD -54,721 | The ETF sold 125 shares of ELV on 2025-04-15. The shares were previously bought for an average price of USD 410.613. The Elevance Health Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 3,395 The average price that the ETF previously sold ELV share for is USD 402.099 so the ETF has sold 125 shares on 2025-04-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 437.77 | USD -54,721 | The ETF sold 125 shares of ELV on 2025-04-15. The shares were previously bought for an average price of USD 410.613. The Elevance Health Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 3,395 The average price that the ETF previously sold ELV share for is USD 402.099 so the ETF has sold 125 shares on 2025-04-15 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,105 @ USD 50 | USD -55,250 | The ETF sold 1105 shares of BMY on 2025-04-15. The shares were previously bought for an average price of USD 58.1671. The Bloomsbury Publishing Plc shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 9,025 The average price that the ETF previously sold BMY share for is USD 56.9808 which is higher than the selling price of USD 50 on 2025-04-15. |
| MDT - Medtronic PLC | SELL | -698 @ USD 82.37 | USD -57,494 | The ETF sold 698 shares of MDT on 2025-04-15. The shares were previously bought for an average price of USD 89.2052. The Medtronic PLC shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,771 The average price that the ETF previously sold MDT share for is USD 85.4263 which is higher than the selling price of USD 82.37 on 2025-04-15. |
| SYK - Stryker Corporation | SELL | -186 @ USD 346.8 | USD -64,505 | The ETF sold 186 shares of SYK on 2025-04-15. The shares were previously bought for an average price of USD 380.491. The Stryker Corporation shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 6,267 The average price that the ETF previously sold SYK share for is USD 374.67 which is higher than the selling price of USD 346.8 on 2025-04-15. |
| DHR - Danaher Corporation | SELL | -348 @ USD 189.92 | USD -66,092 | The ETF sold 348 shares of DHR on 2025-04-15. The shares were previously bought for an average price of USD 218.674. The Danaher Corporation shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 10,006 The average price that the ETF previously sold DHR share for is USD 233.312 which is higher than the selling price of USD 189.92 on 2025-04-15. |
| DHR - Danaher Corporation | SELL | -348 @ USD 189.92 | USD -66,092 | The ETF sold 348 shares of DHR on 2025-04-15. The shares were previously bought for an average price of USD 218.674. The Danaher Corporation shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 10,006 The average price that the ETF previously sold DHR share for is USD 233.312 which is higher than the selling price of USD 189.92 on 2025-04-15. |
| PFE - Pfizer Inc | SELL | -3,083 @ USD 22.44 | USD -69,183 | The ETF sold 3083 shares of PFE on 2025-04-15. The shares were previously bought for an average price of USD 26.0705. The Pfizer Inc shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 11,193 The average price that the ETF previously sold PFE share for is USD 26.1026 which is higher than the selling price of USD 22.44 on 2025-04-15. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 500.49 | USD -69,568 | The ETF sold 139 shares of VRTX on 2025-04-15. The shares were previously bought for an average price of USD 479.413. The Vertex Pharmaceuticals Inc shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 2,930 The average price that the ETF previously sold VRTX share for is USD 464.639 so the ETF has sold 139 shares on 2025-04-15 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -678 @ USD 105.68 | USD -71,651 | The ETF sold 678 shares of GILD on 2025-04-15. The shares were previously bought for an average price of USD 102.997. The Guild Esports Plc shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 1,819 The average price that the ETF previously sold GILD share for is USD 94.0981 so the ETF has sold 678 shares on 2025-04-15 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -802 @ USD 94.23 | USD -75,572 | The ETF sold 802 shares of BSX on 2025-04-15. The shares were previously bought for an average price of USD 98.4145. The Boston Scientific Corporation shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,356 The average price that the ETF previously sold BSX share for is USD 89.935 so the ETF has sold 802 shares on 2025-04-15 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -802 @ USD 94.23 | USD -75,572 | The ETF sold 802 shares of BSX on 2025-04-15. The shares were previously bought for an average price of USD 98.4145. The MULSTRXSSXIMETFP shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,356 The average price that the ETF previously sold BSX share for is USD 89.935 so the ETF has sold 802 shares on 2025-04-15 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 295.3 | USD -86,228 | The ETF sold 292 shares of AMGN on 2025-04-15. The shares were previously bought for an average price of USD 305.685. The Amgen Inc shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,032 The average price that the ETF previously sold AMGN share for is USD 290.024 so the ETF has sold 292 shares on 2025-04-15 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -208 @ USD 441 | USD -91,728 | The ETF sold 208 shares of TMO on 2025-04-15. The shares were previously bought for an average price of USD 530.968. The Time Out Group plc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 18,713 The average price that the ETF previously sold TMO share for is USD 527.2 which is higher than the selling price of USD 441 on 2025-04-15. |
| ISRG - Intuitive Surgical Inc | SELL | -193 @ USD 488.27 | USD -94,236 | The ETF sold 193 shares of ISRG on 2025-04-15. The shares were previously bought for an average price of USD 543.288. The Intuitive Surgical Inc shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of USD 10,618 The average price that the ETF previously sold ISRG share for is USD 530.105 which is higher than the selling price of USD 488.27 on 2025-04-15. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 78.39 | USD -107,786 | The ETF sold 1375 shares of MRK on 2025-04-15. The shares were previously bought for an average price of USD 93.0405. The Marks Electrical Group PLC shares were sold for -15.7% lower than average price of previous purchases. This resulted in an overall loss of USD 20,144 The average price that the ETF previously sold MRK share for is USD 99.6749 which is higher than the selling price of USD 78.39 on 2025-04-15. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 78.39 | USD -107,786 | The ETF sold 1375 shares of MRK on 2025-04-15. The shares were previously bought for an average price of USD 93.0405. The Merck & Company Inc shares were sold for -15.7% lower than average price of previous purchases. This resulted in an overall loss of USD 20,144 The average price that the ETF previously sold MRK share for is USD 99.6749 which is higher than the selling price of USD 78.39 on 2025-04-15. |
| ABT - Abbott Laboratories | SELL | -942 @ USD 126.22 | USD -118,899 | The ETF sold 942 shares of ABT on 2025-04-15. The shares were previously bought for an average price of USD 126.661. The Abbott Laboratories shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 415 The average price that the ETF previously sold ABT share for is USD 117.185 so the ETF has sold 942 shares on 2025-04-15 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -958 @ USD 176.8 | USD -169,374 | The ETF sold 958 shares of ABBV on 2025-04-15. The shares were previously bought for an average price of USD 194.397. The AbbVie Inc shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 16,858 The average price that the ETF previously sold ABBV share for is USD 185.336 which is higher than the selling price of USD 176.8 on 2025-04-15. |
| JNJ - Johnson & Johnson | SELL | -1,307 @ USD 153.62 | USD -200,781 | The ETF sold 1307 shares of JNJ on 2025-04-15. The shares were previously bought for an average price of USD 158.317. The Johnson & Johnson shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,139 The average price that the ETF previously sold JNJ share for is USD 152.699 so the ETF has sold 1307 shares on 2025-04-15 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -499 @ USD 583.59 | USD -291,211 | The ETF sold 499 shares of UNH on 2025-04-15. The shares were previously bought for an average price of USD 536.071. The UnitedHealth Group Incorporated shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 23,712 The average price that the ETF previously sold UNH share for is USD 565.704 so the ETF has sold 499 shares on 2025-04-15 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -427 @ USD 757.18 | USD -323,316 | The ETF sold 427 shares of LLY on 2025-04-15. The shares were previously bought for an average price of USD 842.018. The Eli Lilly and Company shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of USD 36,226 The average price that the ETF previously sold LLY share for is USD 796.79 which is higher than the selling price of USD 757.18 on 2025-04-15. |